Cryopreservation of oocytes to preserve female fertility
Authors:
A. Nesvadbová 1,2
; Š. Machač 1; J. Bezdíček 2
Authors place of work:
IVF Clinic, a. s., Olomouc
1; Přírodovědecká fakulta, UP v Olomouci
2
Published in the journal:
Ceska Gynekol 2026; 91(2): 96-101
Category:
Původní práce
doi:
https://doi.org/10.48095/cccg202696
Summary
Objective: The aim of the study is to obtain information on the possibilities and success rate of cryopreservation of human oocytes. In the Czech Republic, this method is used to prolong women‘s reproductive health to a limited extent due to low awareness among women and also due to the high cost of this method. Materials and methods: Ninety-three oocyte retrievals were evaluated in women with oocyte retrievals intended for vitrification and long-term storage to extend reproductive age. Clients were divided according to age into two groups: under 35 years old and over 35 years old. At the same time, each age group was divided into two groups according to the number of vitrified oocytes: under 4 oocytes and over 4 oocytes. Furthermore, the success rate of the oocyte vitrification method was compared with the success rate of oocyte vitrification in healthy anonymous donors. Results: In order to obtain information on the success rate of the oocyte vitrification method, we evaluated the survival rate (SR), fertilization rate (FR) and utilization rate (UR) in each group. SR was 61.5–89.3%, with the lowest value in older clients with a low oocyte count. FR was 50.0–80.0%, where the lowest value was again seen in older clients with a low oocyte count. UR was 34.9–75.0%, where the lowest value was seen in the group of older clients with a higher vitrified oocyte count compared to the other groups. Conclusion: In conclusion, the age at the time of oocyte freezing and the number of stored oocytes remain the two key factors that determine the success rate to secure the possibility of having a child in the future.
Keywords:
oocyte – fertility – vitrification – preservation
Zdroje
1. Sciorio R, Pluchino N, Fuller BJ. Review of human oocyte cryopreservation in ART programs: current challenges and opportunities. Cryobiology 2023; 113 : 104590. doi: 10.1016/ j.cryobiol.2023.104590.
2. Fouks Y, Sakkas D, Bortoletto PE et al. Utilization of cryopreserved oocytes in patients with poor ovarian response after planned oocyte cryopreservation. JAMA Netw Open 2024; 7 (1): e2349722. doi: 10.1001/jamanetworkopen. 2023.49722.
3. Chatziparasidou A. Improving oocyte freezing for advanced maternal age. J Reprod Med Embryol 2024; 1 (1): 10–17. doi: 10.21608/jrme.2024.261045.1003.
4. Cobo A, Domingo J, Pérez S et al. Vitrification: an effective new approach to oocyte banking and preserving fertility in cancer patients. Clin Transl Oncol 2008; 10 (5): 268–273. doi: 10.1007/s12094-008-0196-7.
5. Antonouli S, Di Nisio V, Messini C et al. A comprehensive review and update on human fertility cryopreservation methods and tools. Front Vet Sci 2023; 10 : 1151254. doi: 10.3389/fvets. 2023.1151254.
6. Liebermann J, Nawroth F, Isachenko V et al. Potencial importance of vitrification in reproductive medicine. Biol Reprod 2002; 67 (6): 1671–1680. doi: 10.1095/biolreprod.102.006833.
7. Fahy GM, MacFarlane DR, Angell CA et al. Vitification as an approach to cryopreservation. Cryobiology 1984; 21 (4): 407–426. doi: 10.1016/0011-2240 (84) 90079-8.
8. Yavin S, Arav A. Measurement of essential physical properties of vitrification solutions. Theriogenology 2007; 67 (1): 81–89. doi: 10.1016/j.theriogenology.2006. 09.029.
9. Arav A, Natan Y, Levi-Setti PE et al. New methods for cooling and storing oocytes and embryos in a clean environment of –196°C. Reprod Biomed Online 2016; 33 (1): 71–78. doi: 10.1016/j.rbmo2016.03.010.
10. Olexiková L, Dujíčková L, Makarevich AV et al. Glutathione during post-thaw recovery culture can mitigate deleterious impact of vitrification on bovine oocytes. Antioxidants 2022; 12 (1): 35. doi: 10.3390/antiox120 10035.
11. Arav A, Natan Y. Vitrification of oocytes: from basic science to clinical application. Adv Exp Med Biol 2013; 761 : 69–83. doi: 10.1007/978 - 1-4614-8214-7_6.
12. Aye M, Di Giorgio C, De Mo M et al. Assessment of the genotoxicity of three cryoprotectants used for human oocyte vitrification: dimethyl sulfoxide, ethylene gylocol and propylene glycol. Food Chem Toxicol 2010; 48 (7): 1905–1912. doi: 10.1016/j.fct.2010. 04.032.
13. Cai H, Niringiyumukiza JD, Li Y et al. Open versus closed vitrification system of human oocytes and embryos: a systematic review and meta-analysis of embryologic and clinical outcomes. Reprod Biol Endocrinol 2018; 16 (1): 123. doi: 10.1186/s12958-018-0440-0.
14. Alpha Scientists in Reproductive Medicine. The Alpha consensus meeting on cryopreservation key performance indicators and benchmarks: proceeding of an expert meeting. Reprod Biomed Online 2012; 25 (2): 146–167. doi: 10.1016/j.rbmo.2012.05.006.
15. Katsani D, Paraschou N, Panagouli E et al. Social egge freezing – a trend or modern reality? J Clin Med 2024; 13 (2): 390. doi: 10.3390/jcm13020390.
16. Eichenlaub-Ritter U. Oocyte ageing and its cellular basis. Int J Dev Biol 2012; 56 (10–12): 841–852. doi: 10.1387/ijdb.120141ue.
17. Sharma N, Coticchio G, Borini A et al. Changes in DNA repair compartments and cohesin loss promote DNA damage accumulation in aged oocytes. Curr Biol 2024; 34 (22): 5131.e6–5148.e6. doi: 10.1016/j.cub.2024. 09.040.
18. ESHRE Special Interest Group of Embryology, Alpha Scientists in Reproductive Medicine. The Vienna consensus: report of an expert meeting on the development of art laboratory performance indicators. Reprod Biomed Online 2017; 35 (5): 494–510. doi: 10.1016/ j.rbmo.2017.06.015.
19. Cobo A, García-Velasco JA, Coello A et al. Oocyte vitrification as an efficient option for elective fertility preservation. Fertil Steril 2016; 105 (3): 755.e8–764.e8. doi: 10.1016/ j.fertnstert.2015.11.027.
20. Garratt J, Shah T, McLaughlin A et al. Clinical outcomes of vitrified-warmed autologous oocyte cycles with 15-year follow-up at a single UK centre: consistent and predictable results. Reprod Biomed Online 2025; 50 (1): 104376. doi: 10.1016/j.rbmo.2024.104376.
21. Chang CC, Shapiro DB, Nagy ZP. The effects of vitrification on oocyte quality. Biol Reprod 2022; 106 (2): 316–327. doi: 10.1093/biolre/ioab 239.
22. Cobo A, García-Velasco JA, Remohí J et al. Oocyte vitrification for fertility preservation for both medical and nonmedical reasons. Fertil Steril 2021; 115 (5): 1091–1101. doi: 10.1016/ j.fertnstert.2021.02.006.
23. Kasaven LS, Jones BP, Heath C et al. Reproductive outcomes from ten years of elective oocyte cryopreservation. Arch Gynecol Obstet 2022; 306 (5): 1753–1760. doi: 10.1007/s00404-022-06711-0.
24. Kawwass JF, Crawford S, Hipp HS. Frozen eggs: national autologous oocyte thaw outcomes. Fertil Steril 2021; 116 (4): 1077–1084. doi: 10.1016/j.fertnstert.2021.05.080.
Štítky
Dětská gynekologie Gynekologie a porodnictví Reprodukční medicínaČlánek vyšel v časopise
Česká gynekologie
2026 Číslo 2
Nejčtenější v tomto čísle
- Vliv angiogenních faktorů a mateřské endoteliální dysfunkce na výsledek těhotenství
- Vliv vybraných rozměrů struktur pánevního dna na průběh porodu – přehled literatury
- Kryokonzervace oocytů pro zachování ženské plodnosti
- Perinatální výsledky u těžké preeklampsie s peritoneálním ascitem – zkušenosti z jednoho terciárního centra